Mitchell Mcleod Pugh & Williams Inc. grew its holdings in Clorox Co (NYSE:CLX) by 9.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 6,574 shares of the company’s stock after acquiring an additional 550 shares during the quarter. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Clorox were worth $1,013,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also added to or reduced their stakes in CLX. United Capital Management of KS Inc. grew its stake in Clorox by 2.9% during the 4th quarter. United Capital Management of KS Inc. now owns 3,637 shares of the company’s stock worth $561,000 after buying an additional 103 shares during the last quarter. JGP Wealth Management LLC lifted its position in Clorox by 1.1% during the 3rd quarter. JGP Wealth Management LLC now owns 16,484 shares of the company’s stock worth $2,479,000 after acquiring an additional 180 shares during the period. Private Trust Co. NA lifted its position in Clorox by 5.3% during the 4th quarter. Private Trust Co. NA now owns 4,522 shares of the company’s stock worth $697,000 after acquiring an additional 229 shares during the period. Meiji Yasuda Asset Management Co Ltd. lifted its position in Clorox by 3.2% during the 3rd quarter. Meiji Yasuda Asset Management Co Ltd. now owns 10,343 shares of the company’s stock worth $1,556,000 after acquiring an additional 320 shares during the period. Finally, People s United Financial Inc. lifted its position in Clorox by 2.1% during the 3rd quarter. People s United Financial Inc. now owns 16,916 shares of the company’s stock worth $2,545,000 after acquiring an additional 342 shares during the period. Institutional investors and hedge funds own 77.73% of the company’s stock.
In other news, SVP Diego J. Barral sold 12,880 shares of the firm’s stock in a transaction that occurred on Tuesday, November 6th. The stock was sold at an average price of $157.98, for a total value of $2,034,782.40. Following the completion of the sale, the senior vice president now directly owns 18,603 shares of the company’s stock, valued at approximately $2,938,901.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Michael R. Costello sold 6,882 shares of the firm’s stock in a transaction that occurred on Thursday, November 15th. The shares were sold at an average price of $160.08, for a total value of $1,101,670.56. The disclosure for this sale can be found here. Insiders sold a total of 313,228 shares of company stock valued at $50,910,506 over the last three months. Insiders own 1.40% of the company’s stock.
A number of analysts have weighed in on the company. Zacks Investment Research reaffirmed a “sell” rating on shares of Clorox in a research report on Monday, November 12th. ValuEngine raised Clorox from a “hold” rating to a “buy” rating in a research report on Saturday, September 22nd. Wells Fargo & Co increased their price objective on Clorox from $145.00 to $160.00 and gave the stock a “market perform” rating in a research report on Wednesday, December 12th. They noted that the move was a valuation call. Bank of America reaffirmed a “neutral” rating and set a $170.00 price objective (up from $150.00) on shares of Clorox in a research report on Thursday, December 6th. Finally, Citigroup increased their price objective on Clorox from $149.00 to $153.00 and gave the stock a “neutral” rating in a research report on Friday, November 2nd. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. Clorox has a consensus rating of “Hold” and a consensus target price of $148.08.
Shares of CLX traded up $2.17 during mid-day trading on Thursday, hitting $153.11. The company’s stock had a trading volume of 1,457,415 shares, compared to its average volume of 1,340,074. The company has a debt-to-equity ratio of 3.38, a current ratio of 1.07 and a quick ratio of 0.65. The stock has a market capitalization of $19.54 billion, a P/E ratio of 24.46, a P/E/G ratio of 3.76 and a beta of 0.39. Clorox Co has a 1-year low of $113.57 and a 1-year high of $167.70.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 31st. The company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.59 by $0.03. The business had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.53 billion. Clorox had a return on equity of 102.65% and a net margin of 13.59%. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same period last year, the firm earned $1.46 EPS. Research analysts anticipate that Clorox Co will post 6.31 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 8th. Stockholders of record on Wednesday, January 23rd will be issued a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, January 22nd. This represents a $3.84 annualized dividend and a dividend yield of 2.51%. Clorox’s dividend payout ratio is currently 61.34%.
TRADEMARK VIOLATION WARNING: “Clorox Co (CLX) Stake Lifted by Mitchell Mcleod Pugh & Williams Inc.” was first posted by Zolmax and is the property of of Zolmax. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://zolmax.com/investing/clorox-co-clx-stake-lifted-by-mitchell-mcleod-pugh-williams-inc/2817206.html.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: How do candlesticks reflect price movement?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.